{"title":"An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic","publication":"Vaccine","issue":"3","language":[{"iso":"eng"}],"intvolume":" 39","page":"495-504","date_updated":"2024-05-04T15:12:54Z","type":"journal_article","volume":39,"publisher":"Elsevier BV","citation":{"bibtex":"@article{Rastegar_Tavana_Meraj_Mina_2021, title={An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic}, volume={39}, DOI={10.1016/j.vaccine.2020.12.022}, number={3}, journal={Vaccine}, publisher={Elsevier BV}, author={Rastegar, Mehdi and Tavana, Madjid and Meraj, Afshin and Mina, Hassan}, year={2021}, pages={495–504} }","ieee":"M. Rastegar, M. Tavana, A. Meraj, and H. Mina, “An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic,” Vaccine, vol. 39, no. 3, pp. 495–504, 2021, doi: 10.1016/j.vaccine.2020.12.022.","ama":"Rastegar M, Tavana M, Meraj A, Mina H. An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic. Vaccine. 2021;39(3):495-504. doi:10.1016/j.vaccine.2020.12.022","short":"M. Rastegar, M. Tavana, A. Meraj, H. Mina, Vaccine 39 (2021) 495–504.","apa":"Rastegar, M., Tavana, M., Meraj, A., & Mina, H. (2021). An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic. Vaccine, 39(3), 495–504. https://doi.org/10.1016/j.vaccine.2020.12.022","mla":"Rastegar, Mehdi, et al. “An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries during the COVID-19 Pandemic.” Vaccine, vol. 39, no. 3, Elsevier BV, 2021, pp. 495–504, doi:10.1016/j.vaccine.2020.12.022.","chicago":"Rastegar, Mehdi, Madjid Tavana, Afshin Meraj, and Hassan Mina. “An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries during the COVID-19 Pandemic.” Vaccine 39, no. 3 (2021): 495–504. https://doi.org/10.1016/j.vaccine.2020.12.022."},"department":[{"_id":"277"}],"publication_status":"published","date_created":"2024-05-04T14:34:46Z","doi":"10.1016/j.vaccine.2020.12.022","status":"public","_id":"53874","publication_identifier":{"issn":["0264-410X"]},"user_id":"51811","year":"2021","author":[{"first_name":"Mehdi","last_name":"Rastegar","full_name":"Rastegar, Mehdi"},{"full_name":"Tavana, Madjid","last_name":"Tavana","first_name":"Madjid","id":"31858"},{"first_name":"Afshin","last_name":"Meraj","full_name":"Meraj, Afshin"},{"first_name":"Hassan","full_name":"Mina, Hassan","last_name":"Mina"}]}